C
Circio Holding ASA
OSE:CRNA
Circio Holding ASA
OSE:CRNA
Price:
2.64
NOK
23.65%
Market Closed
Market Cap:
kr379.2m
Relative Value
The Relative Value of one CRNA stock under the Base Case scenario is hidden NOK. Compared to the current market price of 2.64 NOK, Circio Holding ASA is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CRNA Relative Value
HIDDEN
Multiples Across Competitors
CRNA Competitors Multiples
Circio Holding ASA Competitors
Circio Holding ASA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NO |
C
|
Circio Holding ASA
OSE:CRNA
|
391.6m NOK | 0 | -42.6 | -9.6 | -9.6 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
407.6B USD | 6.8 | 173.5 | 16.7 | 23.8 | |
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
326.4B USD | 462 374.5 | -2 631.9 | -2 389.6 | -2 389.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
208.4B USD | 5.7 | 27 | 15.4 | 15.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
185.3B USD | 6.3 | 21.8 | 14.8 | 14.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
125.9B USD | 10.5 | 31.8 | 24.4 | 25.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD | 5.7 | 18.3 | 13.7 | 15.7 | |
| AU |
|
CSL Ltd
ASX:CSL
|
70.9B AUD | 3.2 | 16.7 | 11.4 | 14.3 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.9B EUR | 13.1 | 30.9 | 52.4 | 53.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
